Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome (2021)

First Author: Roberts I
Attributed to:  Untargeted metabolomics of serum samples during COVID-19 disease progression funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11306-021-01859-3

PubMed Identifier: 34928464

Publication URI: http://europepmc.org/abstract/MED/34928464

Type: Journal Article/Review

Parent Publication: Metabolomics

Issue: 1

ISSN: 1573-3882